[Why may reactivators be harmful? Transacted on the example of reactivation of the blockaded acetylcholinesterase].
D001665:Binding Sites; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D004336:Drug Antagonism; D004789:Enzyme Activation; D006801:Humans; D008956:Models, Chemical; D010091:Oximes / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D010756:Phosphoric Acids / Q000506:poisoning*; D011220:Pralidoxime Compounds / Q000037:antagonists & inhibitors
D002800:Cholinesterase Inhibitors; D010091:Oximes; D010756:Phosphoric Acids; D011220:Pralidoxime Compounds
Warum können Reaktivatoren schädlich sein? Abgehandelt am Beispiel der Reaktivierung der blockierten Acetylcholinesterase.